These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Intraoperative magnetic resonance imaging and early prognosis for vision after transsphenoidal surgery for sellar lesions. Berkmann S; Fandino J; Zosso S; Killer HE; Remonda L; Landolt H J Neurosurg; 2011 Sep; 115(3):518-27. PubMed ID: 21639700 [TBL] [Abstract][Full Text] [Related]
5. Visual parameters in patients with pituitary adenoma before and after transsphenoidal surgery. Marcus M; Vitale S; Calvert PC; Miller NR Aust N Z J Ophthalmol; 1991 May; 19(2):111-8. PubMed ID: 1930993 [TBL] [Abstract][Full Text] [Related]
6. Neuro-ophthalmologic exploration in non-functioning pituitary adenoma. Abouaf L; Vighetto A; Lebas M Ann Endocrinol (Paris); 2015 Jul; 76(3):210-9. PubMed ID: 26070465 [TBL] [Abstract][Full Text] [Related]
8. Visual acuity and pattern of visual field loss at presentation in pituitary adenoma. Ogra S; Nichols AD; Stylli S; Kaye AH; Savino PJ; Danesh-Meyer HV J Clin Neurosci; 2014 May; 21(5):735-40. PubMed ID: 24656736 [TBL] [Abstract][Full Text] [Related]
9. [The clinical study of the damage of visual function caused by pituitary tumor]. Qi C; Li Q; Wang D; Dong L; Yang J; Li Q; Chen M Yan Ke Xue Bao; 2008 Mar; 24(1):62-4. PubMed ID: 18709961 [TBL] [Abstract][Full Text] [Related]
10. Reassessment of the role of radiation therapy in the treatment of endocrine-inactive pituitary macroadenomas. Lillehei KO; Kirschman DL; Kleinschmidt-DeMasters BK; Ridgway EC Neurosurgery; 1998 Sep; 43(3):432-8; discussion 438-9. PubMed ID: 9733298 [TBL] [Abstract][Full Text] [Related]
11. Integration of surgery with fractionated stereotactic radiotherapy for treatment of nonfunctioning pituitary macroadenomas. Paek SH; Downes MB; Bednarz G; Keane WM; Werner-Wasik M; Curran WJ; Andrews DW Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):795-808. PubMed ID: 15708259 [TBL] [Abstract][Full Text] [Related]
13. Gonadotroph adenoma of the pituitary gland: a clinicopathologic analysis of 100 cases. Young WF; Scheithauer BW; Kovacs KT; Horvath E; Davis DH; Randall RV Mayo Clin Proc; 1996 Jul; 71(7):649-56. PubMed ID: 8656706 [TBL] [Abstract][Full Text] [Related]
14. [Visual acuity outcome and recurrence in large or huge pituitary adenomas operated with transcranial approach: comparison between frontotemporal and interhemispheric approaches]. Kurokawa Y; Uede T; Niwa J; Daibo M; Hashi K No Shinkei Geka; 1998 Sep; 26(9):813-21. PubMed ID: 9757458 [TBL] [Abstract][Full Text] [Related]
15. Stereotactic radiotherapy for the treatment of pituitary adenomas. Selch MT; Gorgulho A; Lee SP; Mattozo C; Solberg TD; Agazaryan N; Desalles AA Minim Invasive Neurosurg; 2006 Jun; 49(3):150-5. PubMed ID: 16921455 [TBL] [Abstract][Full Text] [Related]
17. External radiotherapy of pituitary adenomas. Zierhut D; Flentje M; Adolph J; Erdmann J; Raue F; Wannenmacher M Int J Radiat Oncol Biol Phys; 1995 Sep; 33(2):307-14. PubMed ID: 7673017 [TBL] [Abstract][Full Text] [Related]
18. [A case of radiation optic neuropathy after resection of a pituitary adenoma]. Yoshii M; Okisaka S; Yanagawa Y; Takiguchi H Nippon Ganka Gakkai Zasshi; 1995 Jun; 99(6):739-44. PubMed ID: 7611012 [TBL] [Abstract][Full Text] [Related]
19. Observation alone after transsphenoidal surgery for nonfunctioning pituitary macroadenoma. Dekkers OM; Pereira AM; Roelfsema F; Voormolen JH; Neelis KJ; Schroijen MA; Smit JW; Romijn JA J Clin Endocrinol Metab; 2006 May; 91(5):1796-801. PubMed ID: 16507632 [TBL] [Abstract][Full Text] [Related]
20. Outcome of fractionated stereotactic radiotherapy in patients with pituitary adenomas resistant to conventional treatments: a 5.25-year follow-up study. Schalin-Jäntti C; Valanne L; Tenhunen M; Setälä K; Paetau A; Sane T; Kouri M Clin Endocrinol (Oxf); 2010 Jul; 73(1):72-7. PubMed ID: 20039898 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]